Clinical trial Recruiting at 1 site Observational Ages 18 and up

Impact of Sjögren's syndrome on quality of life and costs

Official title: The Medico-economic Impact and Quality of Life of the Small-fiber Neuropathy Associated by Using Validated Scales (SF36, DN4, PROFAD SSI, ESPRI)

Run by Assistance Publique - Hôpitaux de Paris · NCT03509064 · Data updated 2026-11-12

This study is trying to see how small fiber neuropathy affects the quality of life and costs for people with Sjögren's syndrome.

More Quality of Life (QOL) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedJanuary 14, 2019
Main results expectedJanuary 14, 2027
Study endsJanuary 14, 2027
Registry record updatedFebruary 5, 2026
Trial IDNCT03509064 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with a confirmed diagnosis of primary Sjögren syndrome, particularly those experiencing small fiber neuropathy.

Probably not a fit

Patients with other causes of peripheral neuropathy or those currently receiving biologics or immunoglobulin therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the impact of small fiber neuropathy (SFN) on the quality of life and the economic burden for patients with primary Sjögren's syndrome. It will involve a monocentric approach at the Lariboisière Fernand Widal Hospital, where patients will be classified into two groups: those with Sjögren's syndrome and SFN, and those without neuropathy. The study will utilize validated questionnaires to gather data on quality of life, pain, and associated healthcare costs, focusing on identifying predictors of impairment and economic impact.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the management and support of patients with Sjögren's syndrome and SFN, potentially improving their quality of life.

How similar studies have gone: While there is ongoing research into Sjögren's syndrome and neuropathy, this specific focus on the economic and quality of life impacts is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Definite primary Sjögren syndrome
* Age over 18 years
* No biologics nor immunoglobulin therapy during the 6 months before study onset

Arm 1: patients with a small fiber neuropathy defined by the presence of a clinical AND one paraclinical abnormality

* (i) Clinical signs of small fibers involvement: thermo-algic sensory deficit or autonomic dysfunction or neuropathic pain with DN4 ≥4;
* AND
* (ii) Small fibers neurophysiological abnormalities (QST, laser evoked potentials, autonomic nervous system tests (sympathetic skin response test or Sudoscan®)
* OR
* (iii) abnormal intraepidermal nerve fiber density (skin biopsy)

Arm2 (control group): patients without signs of peripheral neuropathy (small or large fiber)

Exclusion Criteria:

* Presence of other causes of peripheral neuropathy

  * Acquired: Diabetes, AL amyloidosis, Alcoholism, celiac disease, Drugs, toxic, HIV, Sarcoidosis, systemic vasculitis, Guillain-Barré syndrome.
  * Hereditary: Transthyretin hereditary amyloidosis (TTR), hereditary sensory and autonomic neuropathy (HSAN), Fabry's disease
* Patients with impaired thermo-algic sensitivity and / or dysautonomia and / or pain with DN4 ≥ 4 AND normal diagnostic tests (normal neurophysiological tests AND normal skin biopsy) are excluded.

Where it's running

  • Département de Médecine Interne - Hôpital Lariboisière
    Paris, France
    Recruiting

Study contacts

  • Principal investigator: Damien SÈNE — Assistance Publique - Hôpitaux de Paris
  • Study coordinator: Damien SÈNE, MD, PhD
  • Email: damien.sene@aphp.fr
  • Phone: +33149956380

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.